Empagliflozin
Empagliflozin is one of the two active ingredients in Glyxambi, a tablet that also contains linagliptin. Glyxambi is used for Type 2 Diabetes Mellitus. The product is supplied as a 25/5mg tablet.
Medicine containing Empagliflozin
Key points
- Empagliflozin is an active ingredient in Glyxambi, alongside linagliptin.
- Glyxambi is a tablet.
- Glyxambi is used for Type 2 Diabetes Mellitus.
What empagliflozin is used for
Glyxambi combines empagliflozin with linagliptin in one tablet. Its stated use is Type 2 Diabetes Mellitus. The diabetes management section covers products for this condition, and the Type 2 Diabetes Mellitus page gives background on the condition. Both empagliflozin and linagliptin are active ingredients in the combination. Both names appear in the ingredient list.
How the combination is supplied
Empagliflozin appears with linagliptin in Glyxambi. The product is a tablet, and its strength is written as 25/5mg. The name Glyxambi refers to the combination, not to either ingredient on its own. The tablet contains both active ingredients.
Glyxambi tablets
MayChemist offers Glyxambi 25/5mg tablets. Pharmacy partners in India ship orders to Malaysia in discreet packaging. The tablet contains empagliflozin and linagliptin in a fixed combination. The product name and strength are written as Glyxambi 25/5mg.
Safety and supervision
Empagliflozin in Glyxambi is a combination treatment, so the full ingredient list matters. A doctor or pharmacist can check suitability, contraindications, side effects and interactions with other medicines. This includes medicines bought without a prescription, supplements and herbal products. If you are unsure whether the tablet is suitable, ask before using it. Keep the product information available and follow the advice you are given. Do not stop or alter the tablet without professional advice. Read the product information before use and keep it for reference. A pharmacist can also answer questions about the product.
Further reading
Last updated